Glycated Hemoglobin (HbA1c) as a Predictor of Outcomes during Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Evgenia Papathanassiou, Andriana Ι. Papaioannou, Ιlias Papanikolaou, Emmanouil Antonakis, Ioanna Makou, Georgios Hillas, Eleutheria Mizi, Petros Bakakos, Vasiliki Apollonatou, Galateia Verykokou, Nikolaos Roussakis, Zoe Tsilogianni, Spyros Papiris, Stelios Loukides
Abstract
= .038]. However, duration of hospitalization, death during hospitalization as well as the number of new exacerbation events, time to next exacerbation and mortality during the following year did not differ significantly. Moreover, none of the HbA1c-adjusted glycemic variables examined, demonstrated any statistical significance. In conclusion neither the preceding nor the present glycemic state exhibit a predictive value regarding short- or long-term outcomes of an AECOPD.
Topics & Concepts
Pulmonary diseaseMedicineGlycated hemoglobinInternal medicineIntensive care medicineHemoglobinCardiologyDiseaseDiabetes mellitusType 2 diabetesEndocrinologyChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and MechanismsCardiovascular Function and Risk Factors